First National Bank of Omaha lessened its position in Balchem Co. (NASDAQ:BCPC – Get Rating) by 16.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,268 shares of the basic materials company's stock after selling 2,726 shares during the period. First National Bank of Omaha's holdings in Balchem were worth $1,951,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of BCPC. Assenagon Asset Management S.A. raised its position in shares of Balchem by 86.5% in the first quarter. Assenagon Asset Management S.A. now owns 156,263 shares of the basic materials company's stock valued at $21,361,000 after buying an additional 72,477 shares during the last quarter. Renaissance Technologies LLC raised its position in shares of Balchem by 32.4% in the first quarter. Renaissance Technologies LLC now owns 259,700 shares of the basic materials company's stock valued at $35,501,000 after buying an additional 63,500 shares during the last quarter. BlackRock Inc. increased its position in Balchem by 1.0% during the first quarter. BlackRock Inc. now owns 4,890,972 shares of the basic materials company's stock worth $668,595,000 after purchasing an additional 46,959 shares during the last quarter. Geode Capital Management LLC increased its position in Balchem by 8.1% during the fourth quarter. Geode Capital Management LLC now owns 603,823 shares of the basic materials company's stock worth $101,804,000 after purchasing an additional 45,326 shares during the last quarter. Finally, State Street Corp increased its position in Balchem by 4.1% during the first quarter. State Street Corp now owns 1,046,504 shares of the basic materials company's stock worth $143,057,000 after purchasing an additional 41,692 shares during the last quarter. Institutional investors and hedge funds own 89.15% of the company's stock.

Balchem Stock Performance

Shares of BCPC stock opened at $125.71 on Friday. Balchem Co. has a one year low of $110.15 and a one year high of $174.29. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.64 and a current ratio of 2.62. The company has a 50 day moving average price of $131.87 and a 200 day moving average price of $129.67. The firm has a market capitalization of $4.04 billion, a price-to-earnings ratio of 37.64 and a beta of 0.59.

Insiders Place Their Bets

Wall Street Analysts Forecast Growth

Several brokerages recently commented on BCPC. StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a research report on Monday, August 1st. HC Wainwright upped their price target on shares of Balchem from $152.00 to $164.00 and gave the stock a "buy" rating in a research report on Monday, August 22nd.

Balchem Profile

(Get Rating)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

See Also

• Get a free copy of the StockNews.com research report on Balchem (BCPC)
• Is There a Cure for What is Ailing Teladoc Stock?
• No One Told These 3 Stocks It's a Down Week
• Why Medical Products Maker Repligen May Be A Potential Buy
• At 10%, Is Arbor Realty Trust Dividend Worth It?
• Investors Should Tune Into RF Industries

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Get Rating).

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.